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PREECLAMPSIA IS A MAJOR CAUSE of maternal and neonatal mortality worldwide (20, 21) and a major contributor to premature births and intrauterine growth restriction (12) . It occurs in ϳ5-7% of first pregnancies and recurs at an alarming rate of 20-25% (33) . This pregnancy-specific disorder is diagnosed by elevated blood pressure (BP) and proteinuria and characterized by clinical features including edema and coagulation abnormalities (28) . Although many of the clinical and physiological manifestations associated with preeclampsia resolve soon after delivery, its impact persists in the postpartum period.
Epidemiological studies provide evidence that women with a history of preeclampsia are more likely to develop hypertension compared with women who had normal pregnancies (2, 11, 14, 22, 24) , and women who experience recurrent preeclamptic pregnancies are at even greater risk (7, 30, 31) . Prior preeclampsia is also associated with increased risk of cardiovascular disease (CVD), including myocardial infarction (14, 23) , ischemic heart disease (19) , and stroke (18) .
The underlying mechanism that places women with a history of preeclampsia at risk for hypertension and CVD remains speculative. Endothelial dysfunction, however, is considered a central component of the pathophysiology of preeclampsia and known to contribute to the pathogenesis of hypertension and cardiovascular sequelae. The objective of the present study was to examine whether endothelial function is impaired postpartum in the resistance vessels of women with prior preeclampsia. The presence of endothelial dysfunction could contribute to the elevated BP and increased cardiovascular risk that women with a history of preeclampsia exhibit.
MATERIALS AND METHODS
Study subjects. Fifty healthy women (16 with a history of preeclampsia, 14 women with a prior normal pregnancy, and 20 never pregnant controls) between the ages of 18 and 40 yr were enrolled in this case-control study. Postpartum primiparous participants were recruited from the ongoing longitudinal study entitled Prenatal Exposures and Preeclampsia Prevention (PEPP) conducted at MageeWomens Hospital (MWH), University of Pittsburgh. Briefly, this study enrolled women who presented for prenatal care at MWH clinics and associated obstetrics/gynecology practices at ϳ12-16 wk of gestation and followed them through delivery. In addition, a separate set of participants admitted to rule out preeclampsia at or near the time of labor and delivery was recruited into the parent study, PEPP. On the basis of a review of the medical history and interview information, as well as physiological data and biological specimens, PEPP participants' pregnancy outcomes were classified into diagnostic categories, including those pertinent to this study, i.e., preeclampsia with no preexisting disease and normal pregnancy. Eligible primiparous women were evaluated 6-12 mo after delivery to allow return to prepregnancy physiological baseline; none were nursing. In addition, 20 healthy never pregnant controls, recruited by age and body mass index (BMI) to match the preeclamptic history group, were enrolled into the study.
The study criteria for preeclampsia consisted of a finding of 1) gestational hypertension: elevated BP, Ն30 mmHg change in systolic BP (SBP) or Ն15 mmHg in diastolic BP (DBP) from before 20 wk of gestation or SBP Ն 140 mmHg or DBP Ն 90 mmHg in late pregnancy if prior BP was unavailable; 2) proteinuria within 24 h of labor: urine dipstick with Ն1ϩ protein on a catheterized sample or a reading of Ն2ϩ protein on a random collection or Ն0.3 g protein in 24-h urine collection; and 3) uric acid within 24 h of labor: Ͼ1 SD above normal level for gestational age. Exclusion criteria for all participants were prior history of hypertension (defined as BP Ͼ 140/90) or use of antihypertensive medication, heart disease, diabetes mellitus, renal disease, and current pregnancy confirmed by a urine test. The study protocol was approved by the Institutional Review Board of MWH, and all subjects provided written informed consent.
Study protocol. Participants were evaluated in the General Clinical Research Center of MWH in a quiet, temperature-controlled room (21-23°C) in the morning after a light breakfast while lying supine. They abstained from caffeinated and alcoholic beverages for 12 h and physical activity for 24 h, and smokers refrained for 12 h before being tested. Forearm blood flow (FBF) was measured on the nondominant arm by venous occlusion plethysmography with the use of a mercury in-silastic strain gauge connected to a plethysmograph (EC5R Plethysmograph, DE Hokanson; Bellevue, WA). A wrist cuff was inflated to suprasystolic pressure (200 mmHg) to exclude hand circulation while an upper arm cuff cycled between 15 s of inflation (50 mmHg) and 5 s of deflation during flow measurements (E20 Rapid Cuff Inflator, DE Hokanson). The mean of six to eight consecutive FBF readings comprised baseline FBF. The subjects then rested 15 min to allow time to flush out metabolites and return hand blood flow to normal levels. Next, the Stroop Color Word Test (34) , a mental stress test that induces the fight-or-flight response including endothelium-dependent vasodilatation (8) , was administered. Impairment of stress response is an indicator of endothelial dysfunction. FBF was measured as above, and the peak FBF value was determined. Excess FBF was defined as the difference between peak FBF and mean baseline FBF. The percent increase in FBF was calculated as the ratio of peak FBF to baseline FBF. SBP, DBP, mean arterial pressure (MAP), and heart rate (HR) were measured continuously on the dominant arm with a Dinamap BP monitor (CrikitonVital Signs Monitor Dinamap 1846SX).
Statistical analysis. Values are presented as means Ϯ SE, change over baseline where applicable, or number of subjects and percentages. Differences of mean group values for continuous variables were compared with one-way ANOVA, followed by Bonferroni's correction for multiple comparisons. Nonparametric tests were applied when data were not normally distributed. Univariate comparisons of variables of the postpartum groups, i.e., preeclampsia and normal pregnancy, were performed using the unpaired Student's t-test. Frequencies of categorical variables in the three groups were compared with the 2 -test. Repeated-measures ANOVA was used to evaluate changes in HR and BP of the three groups throughout the study. The association between diagnosis and excess FBF was assessed by linear regression analysis and limited to the postpartum groups. Small sample size necessitated the parsimonious entry of potential confounding variables into the regression model beginning with diagnostic category and baseline FBF. Continuous variables whose means significantly differed in the study groups were then entered to assess the effect of diagnostic category on excess FBF. Statistical analyses were performed using SPSS software (version 11.0, SPSS; Chicago, IL), and significance was accepted at a value of P Ͻ 0.05.
Sample size. Sample size was calculated to assess change in FBF during stress. A study of healthy individuals aged 18-42 yr that utilized the Stroop test reported a change in FBF of 6.5 Ϯ 0.7 ml⅐100 ml Ϫ1 ⅐min Ϫ1 (8) . With the use of these values to calculate sample size in a ratio of 1 preeclamptic case to 1 normal pregnancy control in an unmatched two-tailed analysis, 20 women in each group were needed to provide 80% power to detect a 25% reduction in excess FBF. After a subset of the study sample was enrolled, preliminary analyses were performed. Excess FBF in the preeclampsia subset (n ϭ 16) compared with the normal pregnancy subset (n ϭ 14), was reduced 56% more than double the predicted rate. Therefore, enrollment of postpartum subjects was considered sufficient. In addition, 20 never pregnant controls were evaluated.
RESULTS
Baseline characteristics. A total of 50 women was assessed: 16 women with history of preeclampsia, 14 women with a normal pregnancy, and 20 never pregnant controls ( Table 1) . The three study groups were predominantly Caucasian and comparable in age, oral contraceptive use, and current smoking practice. Compared with the normal pregnancy controls, the women with prior preeclampsia delivered earlier and had a greater body BMI (post hoc comparison, P ϭ 0.0013) at an average of 10 mo postpartum. The stage of menstrual cycle in the noncontraceptive users was evenly distributed among the three groups. Prior reproducibility of the technique did not produce significant differences in flow response during the course of a menstrual cycle (data not shown), so subjects were randomly tested during their cycle.
Baseline HR and FBF were comparable in the three study groups (Table 1) , although baseline HR and BP values were consistently lowest in the normal pregnancy group and highest in the preeclamptic group. SBP and DBP comparisons approached significance (P ϭ 0.06 and 0.08, respectively). MAP differed among the three groups (P ϭ 0.007) and was higher in the preeclamptic subjects compared with the normal pregnancy group (post hoc comparison, P ϭ 0.004).
Stress-induced hemodynamic measurements. Table 2 presents a comparison of stress-induced hemodynamic variables. The mental stress test was associated with a similar change over baseline in HR, BP, and FBF in the three study groups. HR and BP values were highest in the preeclampsia group and lowest in normal pregnancy group. DBP varied significantly and was greater in the preeclamptic group compared with both the normal pregnancy (post hoc comparison, P ϭ 0.03) and never pregnant controls (post hoc comparison, P ϭ 0.04). MAP also differed between the preeclamptic group and normal pregnancy controls (post hoc comparison, P ϭ 0.03).
Stress-induced FBF is described by three measurements: peak FBF, excess FBF (the difference between stress-induced peak FBF and baseline FBF), and percent change in FBF over baseline (the ratio of peak FBF to baseline FBF). The mean values of the preeclamptic group for each of these FBF measurements were less than those of the other groups (Table 2) . Overall group comparison of the percent increase in FBF with stress approached significance (P ϭ 0.06). This measurement was highly variable in the never pregnant group ranging from Ͻ10% to nearly 500% (Fig. 1) . Comparing only the preeclamptic and the normal pregnancy groups, the percent increase in FBF with stress was significantly attenuated in the preeclamptics (91 Ϯ 12% vs. 147 Ϯ 16%, P ϭ 0.006).
Relationship between stress flow response and covariates. To assess whether the observed difference in FBF response to stress could indicate a dissimilar perception of stress between the three study groups, stress perception was assessed after the stress flow study. Stress scores indicated that there was no difference in the groups' mean responses (Kruskal-Wallis test, P ϭ 0.29). We also excluded the possibility that the observed difference in percent change in FBF could be due to disparate change in HR or BP in the study groups by finding no significant difference using repeat-measures ANOVA in percent change in HR (P ϭ 0.47), MAP (P ϭ 0.48), SBP (P ϭ 0.52), or DBP (P ϭ 0.68) among the three groups throughout the study protocol. In addition, activity level as assessed by the Paffenbarger Activity Questionnaire (25) was comparable in the postpartum groups (preeclamptics: 924.5 kcal/wk vs. normotensives: 1,042 kcal/wk, P ϭ 0.313), excluding the effect of activity on the difference in stress flow response.
Multivariate analysis. In multivariate linear regression analysis, diagnosis of preeclampsia was a significant predictor of impaired blood flow response to stress (P ϭ 0.02), after controlling for baseline blood flow alone, and, in addition, MAP (P ϭ 0.04) ( Table 3) . When BMI was entered into the model, the effect of a diagnosis of preeclampsia was attenuated but approached significance (P ϭ 0.09). The final model accounted for ϳ54% of the observed variability in the excess blood flow. The regression suggests that the effect of preeclampsia on stress blood flow may be masked by BMI. Stratified analyses using a BMI cutpoint of 25 illustrate that point estimates of percent change in blood flow were consistently lower in the preeclamptic group (Table 4) . Of note, the percent change of the leaner preeclamptics (102.0) was lower than that observed in the overweight normotensive group (115.79).
DISCUSSION
Endothelial dysfunction is considered a central component of the pathophysiology of preeclampsia (27) and is known to Fig. 1 . Stress-induced percent change in forearm blood flow (FBF) by diagnosis. contribute to the pathogenesis of CVD (9, 10, 16, 26) . This systemic phenomenon plays a major role in the pathogenesis and clinical manifestations of atherosclerosis (4) . A close correlation has been found between vasomotor responses of the coronary arteries and forearm vascular bed (15, 35) . The forearm vascular bed can therefore serve as a useful surrogate for assessing the coronary arteries and provide a mechanism for identifying those at increased cardiovascular risk at a stage amenable to intervention. This study demonstrated that women with a history of preeclampsia exhibit evidence of endothelial dysfunction in the forearm vasculature an average of 10 mo after delivery. Impairment occurred despite resolution of the clinical hypertension that accompanies preeclampsia. Comparable changes in hemodynamic response in the three study groups discounted the possibility that HR or BP changes during stress could explain the observed attenuation in blood flow during the mental stress test. Our results confirm those of a previous study that observed reduced brachial artery dilatation in women with prior preeclampsia a median of 3 yr postpartum (5). To our knowledge, our study provides evidence for the first time that impairment of the central conduit vessles extends to the peripheral vasculature and suggests that endothelial dysfunction in women with prior preeclampsia is systemic in nature.
Thirty-one percent of our preeclamptic participants were obese, supporting the role that obesity plays in the onset of preeclampsia. Obesity and concomitant abnormal maternal lipid metabolism (17) and insulin resistance (32) may have some bearing on the attenuated endothelial-dependent blood flow response observed in the preeclamptic study participants. The trend noted in the multivariate analysis suggests that there is an independent negative effect of preeclampsia on vasodilatory response to stress. Stratified analyses by BMI provide additional support for a negative effect of preeclampsia independent from obesity. Stress-induced flow response in the presence of obesity and prior preeclampsia was less than that found in obese women without preeclampsia. A larger study sample could provide more power to substantiate this speculation.
MAP at baseline, although within the normal range, was significantly higher in the preeclamptic cases compared with the normal pregnancy controls. As a whole, the preeclamptic group exhibited the highest DBP during mental stress. Although controversial, a heightened BP response to mental challenges has been shown to predict subsequent BP levels and risk for atherosclerosis even after adjustment for initial BP levels, age, and BMI (24a).
The problem of identifying an appropriate control group for preeclamptic cases has resulted in disparate findings in the literature regarding future cardiovascular risk. It has been argued, particularly by Chesley (6) , that women with normal pregnancies have a lower rate of CVD later in life than the general population and as such are not appropriate controls for preeclamptic cases. Women with prior normal pregnancies, though, are similar to preeclamptic cases as they have similar exposure to the "stress test" of pregnancy. The normal pregnancy group demonstrated the most favorable cardiovascular profile, i.e., lowest BP, HR, and stress-induced FBF. This observation may reflect preexisting healthy endothelium that accommodated a normal pregnancy. An alternative speculation is that normal pregnancy elicits a positive, long-term effect on endothelial function. The never pregnant group exhibited wide variability in blood flow response and HR and BP measurements. These findings may reflect their lack of exposure to the beneficial effects of cardiovascular remodeling inherent to pregnancy.
Some of the limitations of this research may have affected our findings. First, other unidentified risk factors may contribute to the impaired vasodilatory stress response. Behavioral factors, such as chronic stress, lack of social support, and family demands (13, 29) , as well as biological processes, including genetics, hyperlipidemia, and insulin resistance (1), have been shown to contribute to the development of CVD but were not assessed in this study. Moreover, whereas the normal pregnancy participants were predominantly clinic patients followed longitudinally, the preeclamptic subjects were predominantly private patients recruited at labor and delivery. This leads us to suspect that the observed association between preeclampsia and endothelial dysfunction is, in fact, a conservative estimate because the preeclamptic women were of higher socioeconomic status, a positive predictor of health status (3) .
Despite its limitations, this research study benefited from a number of strengths. Application of stringent diagnostic criteria by a jury of clinicians reduced the possibility of misclassification of essential or gestational hypertension as preeclampsia. We recognize that the cross-sectional nature of the study did not permit assessment of endothelial function before pregnancy but studied the never pregnant control group to provide some insight into endothelial health before pregnancy. The study size was limited but powered to detect a 25% difference in the flow response between the preeclamptic cases and normal pregnancy controls. The observation of a 56% difference in flow in this small cohort strengthens the association between preeclampsia and impaired endothelial function.
In summary, we found that women with a history of preeclampsia exhibit impaired endothelium-dependent vasodilatation to mental stress 1 yr postpartum, which may precurse clinical disease. Although the data are limited, they are provocative because demonstration of a link between preeclampsia and CVD risk, especially if that risk is present in the reproductive years, could identify a subset of women who might benefit from heightened surveillance and early preventative interventions such as weight loss, BP control, and lipid and glycemic control.
